Renate Haselmann

Treatment of primary glioblastoma multiforme with cetuximab, radiotherapy and temozolomide (GERT) – phase I/II trial: study protocol

Stephanie E. Combs, S. Heeger, Renate Haselmann et al. · BMC Cancer · 2006 · 96 citations · Full text

Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial

Stephanie E. Combs, Meinhard Kieser, Stefan Rieken et al. · BMC Cancer · 2010 · 94 citations · Full text

Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: The CINDERELLA trial

Stephanie E. Combs, Iris Burkholder, Lutz Edler et al. · BMC Cancer · 2010 · 84 citations · Full text

Combined treatment of nonsmall cell lung cancer NSCLC stage III with intensity‐modulated RT radiotherapy and cetuximab

Alexandra D Jensen, Marc Münter, Helge Bischoff et al. · Cancer · 2011 · 58 citations

Treatment of patients with atypical meningiomas Simpson grade 4 and 5 with a carbon ion boost in combination with postoperative photon radiotherapy: The MARCIE Trial

Stephanie E. Combs, Lutz Edler, Iris Burkholder et al. · BMC Cancer · 2010 · 53 citations · Full text